Users Manual Part 1

IBA | xxiv |
Clinical User’s Guide
Volume 1 - Treatment Session
44. Acute toxicity in comprehensive head and neck radiation for nasopharynx and
paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and
intensity modulated radiation therapy. McDonald, MW, et al. Atlanta : s.n., 2016,
Radiation Oncology.
45. Proton therapy for head and neck cancer: expanding the therapeutic window.
Leeman, JE, et al. New-York : s.n., 2017, The Lancet Oncology, Vol. 18, pp. 254-
265.
46. High-dose proton beam therapy for sinonasal mucosal malignant melanoma.
Fuji, H, et al. Nagaizumi : s.n., 2014, Radiation Oncology.
47. Proton radiation for treatment of cancer of the oropharynx: Early experience at
Loma Linda University medical centre using a concomitant boost technique.
Slater, JD, et al. 2, Loma Linda : s.n., 2005, Int J Radiat Oncol Biol Phys, Vol. 62,
pp. 494-500.
48. Long-term outcomes after proton beam therapy for sinonasal squamous cell
carcinoma. Russo, AL, et al. 1, Boston : s.n., 2016, Int J Radiat Oncol Biol Phys,
Vol. 95, pp. 368-376.
49. Proton beam reirradiation for recurrent head and neck cancer: Multi-institutional
report on feasibility and early outcomes. Romesser, PB, et al. 1, New York : s.n.,
2016, Int J Radiat Oncol Biol Phys, Vol. 95, pp. 386-395.
50. Phase II study of high-dose proton therapy with concurrent chemotherapy for
unresectable stage III non-small cell lung cancer. Chang, JY, et al. Houston : s.n.,
2011, Cancer, pp. 4707-4713.
51. Phase 1 study of dose escalation in hypofractionated proton beam therapy for
non-small cell lung cancer. Gomez, DR, et al. 4, Houston : s.n., 2013, Int J Radiat
Oncol Biol Phys, Vol. 86, pp. 665-670.
52. Long-term outcomes after proton therapy, with concurrent chemotherapy, for
stage II–III inoperable non-small cell lung cancer. Nguyen, QN, et al. Houston :
s.n., 2015, Radiotherapy and Oncology, Vol. 115, pp. 367-372.
53. Hypofractionated high-dose proton beam therapy for stage I non-small cell lung
cancer: Preliminary results of a phase I/II clinical study. Hata, M, et al. 3,
Tsukuba : s.n., 2007, Int J Radiat Oncol Biol Phys, Vol. 68, pp. 786-793.
54. Proton beam therapy for patients with medically inoperable stage I non-small cell
lung cancer at the University of Tsukuba. Nakayama, H, et al. 2, Tsukuba : s.n.,
2010, Int J Radiat Oncol Biol Phys, Vol. 78, pp. 467-471.
55. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular
carcinoma: A phase 2 prospective trial. Bush, DA, et al. Loma Linda : s.n., 2011,
Cancer, pp. 3053-3059.
56. Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162
Patients. Chiba, T, et al. Tsukuba : s.n., 2005, Clinical Cancer Research, pp. 3799-
3805.
57. A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally
advanced pancreatic cancer without distant metastasis. Terashima, K, et al.
Hyogo : s.n., 2012, Radiotherapy and Oncology, Vol. 103, pp. 25-31.